Wed, 13 Jan 2021 14:46:53 GMT
J&J unlikely to meet US vaccine supply goal
Johnson & Johnson will unlikely to meet the US COVID-19 vaccine supply target by spring, as the company faces delays in vaccine production, according to the New York Times report seen on Wednesday.